Anti-hyperglycaemic activity of swietenia macrophylla king (meliaceae) seed extracts in normoglycaemic rats undergoing glucose tolerance tests

Abstract

BackgroundSwietenia macrophylla King (Meliaceae) is used to treat diabetes mellitus in Malaysia. This study aims to evaluate the anti-hyperglycaemic potential of petroleum ether (PE), chloroform (CE) and methanol (ME) extracts of S. macrophylla seeds, in normoglycaemic and streptozotocin (STZ)-induced diabetic rats.MethodsFollowing treatment of normoglycaemic rats with S. macrophylla seed extracts, hypoglycaemic and intraperitoneal glucose tolerance tests (IPGTT) were performed, and blood glucose concentrations were measured. Similarly, glucose concentrations were measured after 1 and 14 days of extract treatment of STZ-induced diabetic rats. Glucose absorption by isolated everted intestine and glucose uptake by isolated abdominal muscle were tested after treatment with seed extracts. Gas chromatography mass spectrometry (GC-MS) analysis was performed on PE of S. macrophylla seeds to identify the compounds responsible for its activity.ResultsNone of the extracts had a significant effect on the blood glucose levels of 60 randomly selected normoglycaemic (normal) and diabetic rats undergoing hypoglycaemic tests. PE, however, significantly reduced blood glucose levels in 30 randomly selected normoglycaemic rats undergoing IPGTT tests 30–120 minutes after glucose administration. Repeated doses of 1000 mg/kg and 500 mg/kg PE to STZ-induced diabetic rats for 14 days did not reduce blood glucose levels significantly. PE did not significantly reduced the intestinal absorption of glucose, but significantly increased glucose uptake by abdominal muscle in the absence or presence of insulin. GC-MS analysis indicated that diterpenes, triterpenoids, fatty acid methyl esters, aldehydes and phytosterols may be responsible for the glucose lowering effects of PE.ConclusionPE extracts of S. macrophylla seeds showed anti-hyperglycaemic activity on IPGTTs . GC-MS analysis on the PE revealed that several compounds, including fucosterol and β-sitosterol, may be responsible for these anti-hyperglycaemic properties.

Effect of Indole-3-Butyric Acid on Clonal Propagation of Swietenia macrophylla through Branch Cutting

“…This is also practiced in Bangladesh (personal observation). Antioxidant, antidiabetic, anti-inflammatory, antimutagenic and antitumor and antifungal, and antihyperglycaemic activities have been reported in many research articles of this species [6,7,9,10].…”

Plant sterols: Friend or foe in CNS disorders?

“…For instance, diabetes is a risk factor for AD and cognitive decline in general [224]. Phytosterols, and in particular fucosterol, have been shown to be anti-diabetic and might therefore modulate cognition indirectly [225][226][227]. However, despite recent advances, longer-term prospective translational studies are mandatory to elucidate the applicability of phytosterols in CNS disorders.…”

Health benefit of fucosterol from marine algae: a review

“…Thus increased attention has been given to the search for personalized antidiabetic candidates. Hashim et al investigated the response of Swietenia macrophylla seed extracts in different in vivo and in vitro diabetic models and validated their antihyperglycemic properties . Swietenia macrophylla King (Meliaceae) is traditionally used to treat diabetes in Malaysia.…”

“…Hashim et al investigated the response of Swietenia macrophylla seed extracts in different in vivo and in vitro diabetic models and validated their antihyperglycemic properties. 27 Swietenia macrophylla King (Meliaceae) is traditionally used to treat diabetes in Malaysia. They investigated the antihyperglycemic potential of petroleum ether (PE), chloroform and methanol (MeOH) extracts of S. macrophylla seeds in normoglycemic and streptozotocin (STZ)-induced diabetic rats.…”